Anavex Life Sciences Corp (AVXL)

[Investor2014]

I followed SPRT and listened in on the public approval review video cast with parents and some the DMD boys in attendance. Dr. Farkas, as you say, was very much towing the old line.

Janet Woodcock, on the other hand, was advising the team as clear as she could without giving a direct order, to please recommend approval based on RWE.

I think you are quite right that AVXL ought to be a clean and easy approval given replication in P2/3 of HAM-D or sooner with the Rett trial on patient and caregiver feedback.